(Q83294818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Claudio Pagano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Paola Zanovello

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

4

Davide Renier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

Alessandra Banzato

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Gilda De Luca

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Fabio Bettella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Giovanni Esposito

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PierFrancesco Bassi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

207-215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

7 January 2021

Focus on bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Superficial bladder cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Current state of immunotherapy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Intravesical therapy for superficial cancer: need for more options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Microtubules as a target for anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Hypersensitivity reactions in ovarian cancer patients receiving paclitaxel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Hypersensitivity reactions from taxol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Anti-neoplastic activity of paclitaxel on experimental superficial bladder cancer: in vivo and in vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Hyaluronan: from extracellular glue to pericellular cue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

CD44 in cancer progression: adhesion, migration and growth regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Synthesis and biological evaluation of a cross-linked hyaluronan-mitomycin C hydrogel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Pharmacologic effects of paclitaxel in human bladder tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.08.020

10.1016/J.UROLONC.2005.08.020

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16678050%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference